MicrobeWorld

The FDA has authorized the emergency use of a molecular diagnostic assay to identify cases of swine flu. The test has not been cleared for marketing by FDA, but the agency granted the US Centers for Disease Control and Prevention the authority to use the multiplex panel to diagnose patients in the US. The rRT-PCR Swine Flu Panel is currently available through a small number of government labs.